Last update:

Immunology news

Oncology & Cancer

Clinical trial: Monoclonal antibody may be an effective alternative to cisplatin in treatment of head and neck cancers

Head and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report. Smokers and drinkers, as well as those with HPV infections, are disproportionately affected.

Oncology & Cancer

Study reveals how glioblastoma evades treatment; identifies potential new treatment strategy

A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment, and introduces a new approach ...

Diseases, Conditions, Syndromes

New thesis on MAIT cells provides insights into immunity and COVID-19

Tobias Kammann from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is defending his thesis titled "The diversity of MAIT cells across the human body and in COVID-19," on 29 November, ...

Oncology & Cancer

Probiotic delivers immunotherapy to shrink gut tumors in mice

Immunotherapy is a promising treatment that recruits the immune system to help fight cancer, but it has had limited success in gastrointestinal cancers. Now, researchers at Washington University School of Medicine in St. ...

Oncology & Cancer

Surprising connection between COVID-19 and cancer regression

A new study led by scientists from the Northwestern Medicine Canning Thoracic Institute and published in the Journal of Clinical Investigation has revealed a connection between COVID-19 infection and cancer regression. The ...

Immunology

Developing an antibody to combat age-related muscle atrophy

We all age. And while humanity's life expectancy has increased dramatically in the modern era, we still struggle with the inevitable health issues our bodies face as we get up in the years. For example, the decrease of muscle ...

Oncology & Cancer

AI analysis of immune cells can predict breast cancer prognosis

Researchers at Karolinska Institutet have investigated how well different AI models can predict the prognosis of triple-negative breast cancer by analyzing certain immune cells inside the tumor. The study, published in the ...

Diseases, Conditions, Syndromes

'Assassin' cells found to play a key role in deadly drug reactions

Researchers have identified the skin cells responsible for orchestrating cases of two of the most life-threatening drug reactions. Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) cause the skin and mucous ...

Immunology

Delayed antibody treatment may improve efficacy of mRNA vaccines

Investigators led by Pablo Penaloza-MacMaster, Ph.D., associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination enhances immune responses and ...

Oncology & Cancer

Lymph node-like structures may trigger the demise of cancer tumors

A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular carcinoma, according to a study by researchers ...

Diseases, Conditions, Syndromes

How the novel antibody felzartamab impacts IgA nephropathy

IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase II trial revealed that felzartamab, an investigational anti-CD38 monoclonal ...

Diseases, Conditions, Syndromes

How SARS-CoV-2 defeats the innate immune response

The novel coronavirus SARS-CoV-2 has an enzyme that can counteract a cell's innate defense mechanism against viruses, explaining why it is more infectious than the previous SARS and MERS-causing viruses. A Kobe University ...